Heartcore Enterprises, Inc. (HTCR) Stock Price & Analysis
Heartcore Enterprises, Inc. (HTCR) fell 13.04% to USD 2 as of September 8, 2026 at 09:09 UTC, according to Nexqual real-time market data.
HTCR last closed at USD 2; the session ranged USD 1.95–2.4 on volume of 42,652 shares. Market capitalization is —, with a 52-week range of USD 1.95–22 (NCM). Source: Nexqual, September 8, 2026 at 09:09 UTC.
Key Statistics (as of September 8, 2026 at 09:09 UTC)
| Price | USD 2 |
|---|---|
| Change | ▼ 13.04% (down) |
| Previous Close | USD 2 |
| Open | USD 2 |
| Day Range | USD 1.95 – 2.4 |
| 52-Week Range | USD 1.95 – 22 |
| Volume | 42,652 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (HTCR)
Nexqual's technical model rates HTCR "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:09 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.15 (neutral) |
| vs SMA50 | Below (USD 2.64) |
| MACD | -0.1 (negative) |
From Heartcore Enterprises, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- We specialize in providing end-to-end advisory and execution support to companies navigating the transition from Japanese domestic standards to the regulatory, financial reporting, and governance requirements applicable to U.S. public companies.   Unlike traditional software-driven sales models, our go-to-market approach is relationship-driven and highly targeted.
- Our partnerships enable us to maintain a steady pipeline of potential clients and enhance our ability to deliver integrated solutions across legal, financial, and operational domains.   Our marketing efforts are focused on establishing thought leadership and building credibility within our target market.
Partnerships
- In connection therewith, in addition to the HeartCore Japan Sale, which closed on October 31, 2025, the Company is assessing all strategic alternatives to divest its 51% equity interest in Sigmaways, Inc. to a third party.   As of the date of this report, the Company has not entered into a definitive agreement with respect to a sale of its equity interest in Sigmaways.
- We consider our relations with our employees to be good.       Government Regulation   Investment Company Act of 1940   Our GO IPO business assists companies in navigating the IPO process in the U.S. markets.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ILAG | Intelligent Living Application | USD 2.9 | ▲ 0% |
| JCSE | JE Cleantech Holdings Limited | USD 1.48 | ▲ 8.46% |
| HSCS | HeartSciences Inc. | USD 3.73 | ▲ 23.92% |
| FRGT | Freight Technologies, Inc. | USD 1.07 | ▼ 10.83% |
| REVB | Revelation Biosciences, Inc. | USD 1.01 | ▲ 1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:09 UTC. This page is informational and not investment advice.